These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 28179220)

  • 1. Modifiable Risk Factors Versus Age on Developing High Predicted Cardiovascular Disease Risk in Blacks.
    Bress AP; Colantonio LD; Booth JN; Spruill TM; Ravenell J; Butler M; Shallcross AJ; Seals SR; Reynolds K; Ogedegbe G; Shimbo D; Muntner P
    J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28179220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicted Atherosclerotic Cardiovascular Disease Risk and Masked Hypertension Among Blacks in the Jackson Heart Study.
    Anstey DE; Booth JN; Abdalla M; Spruill TM; Min YI; Muntner P; Shimbo D
    Circ Cardiovasc Qual Outcomes; 2017 Jul; 10(7):. PubMed ID: 28698190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicted cardiovascular risk for United States adults with diabetes, chronic kidney disease, and at least 65 years of age.
    Jaeger BC; Sakhuja S; Hardy ST; Akinyelure OP; Bundy JD; Muntner P; Whelton PK
    J Hypertens; 2022 Jan; 40(1):94-101. PubMed ID: 34420013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the Pooled Cohort Risk Equations for Cardiovascular Risk Prediction in a Multiethnic Cohort From the Women's Health Initiative.
    Mora S; Wenger NK; Cook NR; Liu J; Howard BV; Limacher MC; Liu S; Margolis KL; Martin LW; Paynter NP; Ridker PM; Robinson JG; Rossouw JE; Safford MM; Manson JE
    JAMA Intern Med; 2018 Sep; 178(9):1231-1240. PubMed ID: 30039172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein(a) levels and risk of cardiovascular disease events in individuals with diabetes mellitus or prediabetes: The Atherosclerosis Risk in Communities study.
    Saeed A; Sun W; Agarwala A; Virani SS; Nambi V; Coresh J; Selvin E; Boerwinkle E; Jones PH; Ballantyne CM; Hoogeveen RC
    Atherosclerosis; 2019 Mar; 282():52-56. PubMed ID: 30685442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ten-year association of coronary artery calcium with atherosclerotic cardiovascular disease (ASCVD) events: the multi-ethnic study of atherosclerosis (MESA).
    Budoff MJ; Young R; Burke G; Jeffrey Carr J; Detrano RC; Folsom AR; Kronmal R; Lima JAC; Liu KJ; McClelland RL; Michos E; Post WS; Shea S; Watson KE; Wong ND
    Eur Heart J; 2018 Jul; 39(25):2401-2408. PubMed ID: 29688297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Frequency of Atherosclerotic Cardiovascular Disease Events Among Primary and Secondary Prevention Subgroups of the Systolic Blood Pressure Intervention Trial.
    Plante TB; Juraschek SP; Zakai NA; Tracy RP; Cushman M
    Am J Cardiol; 2019 Dec; 124(11):1701-1706. PubMed ID: 31575423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Racial Differences in Associations of Blood Pressure Components in Young Adulthood With Incident Cardiovascular Disease by Middle Age: Coronary Artery Risk Development in Young Adults (CARDIA) Study.
    Yano Y; Reis JP; Tedla YG; Goff DC; Jacobs DR; Sidney S; Ning H; Liu K; Greenland P; Lloyd-Jones DM
    JAMA Cardiol; 2017 Apr; 2(4):381-389. PubMed ID: 28199497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of a Lifestyle-Based Tool to Estimate Premature Cardiovascular Disease Events in Young Adults: The Coronary Artery Risk Development in Young Adults (CARDIA) Study.
    Gooding HC; Ning H; Gillman MW; Shay C; Allen N; Goff DC; Lloyd-Jones D; Chiuve S
    JAMA Intern Med; 2017 Sep; 177(9):1354-1360. PubMed ID: 28715555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Normal Systolic Blood Pressure Level With Cardiovascular Disease in the Absence of Risk Factors.
    Whelton SP; McEvoy JW; Shaw L; Psaty BM; Lima JAC; Budoff M; Nasir K; Szklo M; Blumenthal RS; Blaha MJ
    JAMA Cardiol; 2020 Sep; 5(9):1011-1018. PubMed ID: 32936272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and Validation of a Risk Prediction Model for Atherosclerotic Cardiovascular Disease in Japanese Adults: The Hisayama Study.
    Honda T; Chen S; Hata J; Yoshida D; Hirakawa Y; Furuta Y; Shibata M; Sakata S; Kitazono T; Ninomiya T
    J Atheroscler Thromb; 2022 Mar; 29(3):345-361. PubMed ID: 33487620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using Predicted Atherosclerotic Cardiovascular Disease Risk for Discrimination of Awake or Nocturnal Hypertension.
    Sakhuja S; Booth JN; Anstey DE; Jaeger BC; Lewis CE; Lloyd-Jones DM; Schwartz JE; Shimbo D; Shikany JM; Sims M; Muntner P
    Am J Hypertens; 2020 Nov; 33(11):1011-1020. PubMed ID: 32657334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of Nontraditional Risk Markers in Individuals Ineligible for Statin Therapy According to the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines.
    Yeboah J; Polonsky TS; Young R; McClelland RL; Delaney JC; Dawood F; Blaha MJ; Miedema MD; Sibley CT; Carr JJ; Burke GL; Goff DC; Psaty BM; Greenland P; Herrington DM
    Circulation; 2015 Sep; 132(10):916-22. PubMed ID: 26224808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Diet on 10-Year Atherosclerotic Cardiovascular Disease Risk (from the DASH Trial).
    Jeong SY; Wee CC; Kovell LC; Plante TB; Miller ER; Appel LJ; Mukamal KJ; Juraschek SP
    Am J Cardiol; 2023 Jan; 187():10-17. PubMed ID: 36459731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Race on Statin Prescribing for Primary Prevention With High Atherosclerotic Cardiovascular Disease Risk in a Large Healthcare System.
    Dorsch MP; Lester CA; Ding Y; Joseph M; Brook RD
    J Am Heart Assoc; 2019 Nov; 8(22):e014709. PubMed ID: 31707943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-Sensitivity C-Reactive Protein Discordance With Atherogenic Lipid Measures and Incidence of Atherosclerotic Cardiovascular Disease in Primary Prevention: The ARIC Study.
    Quispe R; Michos ED; Martin SS; Puri R; Toth PP; Al Suwaidi J; Banach M; Virani SS; Blumenthal RS; Jones SR; Elshazly MB
    J Am Heart Assoc; 2020 Feb; 9(3):e013600. PubMed ID: 32013698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcomes by atherosclerotic cardiovascular disease risk score and blood pressure level in high risk individuals with type 2 diabetes.
    Harris K; Muntner P; Woodward M; Jun M; Oshima M; Gong J; Harrap S; Menard J; Chalmers J
    J Hum Hypertens; 2023 Mar; 37(3):181-188. PubMed ID: 35184142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparisons of the Framingham and Pooled Cohort Equation Risk Scores for Detecting Subclinical Vascular Disease in Blacks Versus Whites.
    Topel ML; Shen J; Morris AA; Al Mheid I; Sher S; Dunbar SB; Vaccarino V; Sperling LS; Gibbons GH; Martin GS; Quyyumi AA
    Am J Cardiol; 2018 Mar; 121(5):564-569. PubMed ID: 29361288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accuracy of the Atherosclerotic Cardiovascular Risk Equation in a Large Contemporary, Multiethnic Population.
    Rana JS; Tabada GH; Solomon MD; Lo JC; Jaffe MG; Sung SH; Ballantyne CM; Go AS
    J Am Coll Cardiol; 2016 May; 67(18):2118-2130. PubMed ID: 27151343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary Artery Calcium to Guide a Personalized Risk-Based Approach to Initiation and Intensification of Antihypertensive Therapy.
    McEvoy JW; Martin SS; Dardari ZA; Miedema MD; Sandfort V; Yeboah J; Budoff MJ; Goff DC; Psaty BM; Post WS; Nasir K; Blumenthal RS; Blaha MJ
    Circulation; 2017 Jan; 135(2):153-165. PubMed ID: 27881560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.